Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
Recent attention on Waters (WAT) centers on its history of earnings surprises and a positive Earnings ESP, with investors watching the May 5, 2026 report as expectations build around upcoming results.
See our latest analysis for Waters.
Despite optimism around earnings, Waters' recent share price performance has been weak, with a 90 day share price return of a 19.03% decline and a 1 year total shareholder return of a 12.36% decline, suggesting momentum has been fading even as valuation debates and insider buying attract attention.
If earnings surprises are on your radar, this could be a good moment to broaden your watchlist and uncover 17 top founder-led companies
With earnings optimism, insider buying and some valuation tools pointing to a potential discount, the key question now is simple: is Waters genuinely undervalued or are markets already pricing in the company’s future growth?
Most Popular Narrative: 21.9% Undervalued
With Waters last closing at $307.12 and the most followed narrative pointing to a fair value of $393.14, the gap between price and modelled worth is front and center for anyone watching the stock into earnings.
Recurring revenues are accelerating (up 11% this quarter), underpinned by expanding service plan attachments and e-commerce adoption. This enhances revenue stability and net margins and may set up the combined company for more resilient earnings across CapEx cycles.
Read the complete narrative.
Curious what has to happen for that higher value to hold up? The core of this narrative leans on faster top line growth, still healthy margins, and a rich future earnings multiple. The full set of assumptions shows how those pieces fit together to support a price meaningfully above where shares trade today.
Result: Fair Value of $393.14 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, still keep an eye on two pressure points that could derail this upbeat narrative: tougher integration of BD’s Biosciences deal and weaker academic or pharma demand.
Find out about the key risks to this Waters narrative.
Another Way to Look at the Price
The first conclusion that Waters looks undervalued leans on growth forecasts and a discounted cash flow view. Step back and the current P/E of 46.9x versus a fair ratio of 24.2x, a peer average of 28.3x and a global Life Sciences average of 35.3x tells a different story about how much optimism is already in the price. Which signal do you trust more?
Story Continues
See what the numbers say about this price — find out in our valuation breakdown.NYSE:WAT P/E Ratio as at May 2026
Next Steps
With sentiment clearly mixed around valuation, earnings, and recent share price weakness, it makes sense to check the data yourself and move quickly to shape your own view. A good place to start is with a closer look at the 3 key rewards and 1 important warning sign
Looking for more investment ideas?
Waters might be front of mind today, but your next strong idea could be waiting in plain sight if you widen the search and put fresh filters to work.
Target resilient balance sheets and steady fundamentals by running screens through the Simply Wall St solid balance sheet and fundamentals stocks screener (44 results). Hunt for quality at sensible prices by checking companies highlighted in the 50 high quality undervalued stocks. Spot lesser known opportunities before the crowd by reviewing the screener containing 25 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include WAT.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
文章加载中…